患者对人工智能用于皮肤癌筛查与诊断的认知与态度:叙述性综述
该叙述性综述纳入2012至2024年的16项研究,探讨患者对人工智能用于皮肤癌筛查与诊断的认知与态度。患者总体持积极态度,认为人工智能可提高诊断速度与准确性,但更倾向于人工智能辅助皮肤科医生诊断而非替代医生,并担忧隐私泄露、临床医生技能退化及医患关系受影响。
要点
- 患者对人工智能用于皮肤癌筛查诊断总体积极,认可其提速增准。
- 患者偏好人工智能辅助而非替代皮肤科医生进行诊断。
- 患者担忧隐私泄露、医生技能退化及医患关系受威胁。
核心结论
- 患者对人工智能用于皮肤癌筛查与诊断总体持积极态度,但更支持其辅助而非替代皮肤科医生。
研究设计与样本
- 叙述性文献综述,纳入2012至2024年的16项研究,探讨患者对人工智能用于皮肤癌筛查与诊断的认知与态度。
主要发现
- 患者认为人工智能可提高诊断速度与准确性。
- 患者偏好人工智能辅助皮肤科医生诊断而非替代医生。
- 患者担忧人工智能可能导致隐私泄露、临床医生技能退化及威胁医患关系。
- 人口学、质量与功能属性对患者态度的影响具有复杂性。
临床怎么用
- 临床沟通中可强调人工智能的辅助定位,回应患者对隐私与医患关系的关切。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Artificial intelligence (AI) could enable early diagnosis of skin cancer; however, how AI should be implemented in clinical practice is debated. This narrative literature review (16 studies; 2012-2024) explored patient perceptions of AI in skin cancer screening and diagnosis. Patients were generally positive and perceived AI to increase diagnostic speed and accuracy. Patients preferred AI to augment a dermatologist's diagnosis rather than replace it. Patients were concerned that AI could lead to privacy breaches and clinicians deskilling and threaten doctor-patient relationships. Findings also highlight the complex nature of the impact of demographic, quality, and functional attributes on patients' attitudes toward AI.
引用
- Kuppanda PM, Janda M, Soyer HP, et al. What Are Patients' Perceptions and Attitudes Regarding the Use of Artificial Intelligence in Skin Cancer Screening and Diagnosis? Narrative Review. J Invest Dermatol. 2025. PMID: 40019459. doi:10.1016/j.jid.2025.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。